+919405117673
Relugolix Tablets Supplier in South Africa from India | Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical supplier and exporter offering Relugolix Tablets for qualified pharmaceutical buyers, distributors, hospitals, oncology centres and healthcare procurement organisations in South Africa.

Relugolix Tablets – Pharmaceutical Supply from India

Relugolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used as androgen-deprivation therapy for appropriate adult patients with advanced prostate cancer. Relugolix works by reducing testosterone production, helping manage hormone-sensitive prostate cancer. The commonly supplied strength is Relugolix 120 mg Tablets.

Cordium Pharma supports international pharmaceutical sourcing with product information, commercial quotations and export documentation for eligible South African buyers.

Relugolix 120 mg Tablets – Key Information
Active Ingredient: Relugolix
Strength: 120 mg
Dosage Form: Oral tablet
Therapeutic Category: Oncology / Hormonal Therapy
Drug Class: GnRH receptor antagonist
Primary Use: Androgen-deprivation therapy for advanced prostate cancer
Route: Oral administration

Relugolix treatment should be used strictly according to the prescribing information and under the supervision of a qualified healthcare professional.

Relugolix Tablets Supplier for South Africa

Cordium Pharmaceuticals Pvt Ltd can assist South African pharmaceutical distributors, importers, hospitals, oncology procurement teams and authorised healthcare organisations seeking Relugolix tablets from India.

Supply support may include:

Product availability confirmation
Competitive quotation for institutional requirements
Commercial invoice and packing documentation
Export documentation support
Pharmaceutical packaging information
International shipment coordination
Bulk and distributor enquiries
Regulatory Compliance for South Africa

Importation of medicines into South Africa is regulated by the South African Health Products Regulatory Authority (SAHPRA). SAHPRA states that pharmaceutical manufacturers, importers, exporters and wholesalers are subject to licensing and regulatory requirements.

If a medicine is not registered in South Africa, access may require the applicable Section 21 authorisation process. SAHPRA describes Section 21 as a mechanism for authorised access to certain unregistered medicines under specific circumstances.

Therefore, South African buyers should confirm registration, import authorisation and other applicable requirements before placing an order.

Why Choose Cordium Pharmaceuticals?

Cordium Pharmaceuticals Pvt Ltd focuses on international pharmaceutical supply from India, serving customers across multiple global markets. For Relugolix enquiries, our team can provide product details, availability, pricing and export-support information based on the buyer's requirements.

Request a Relugolix Tablets quotation from Cordium Pharmaceuticals Pvt Ltd for supply from India to South Africa.

Frequently Asked Questions

What is Relugolix 120 mg used for?
Relugolix is used as androgen-deprivation therapy for appropriate adult patients with advanced prostate cancer.

Does Cordium Pharma supply Relugolix to South Africa?
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical sourcing and export support for eligible South African buyers, subject to applicable regulations.

Can hospitals and distributors request Relugolix quotations?
Yes. Qualified hospitals, pharmaceutical distributors, importers and procurement organisations can enquire about availability and commercial supply.

Is Relugolix a prescription medicine?
Relugolix should be used only under the supervision of an appropriately qualified healthcare professional.

How can South African buyers request Relugolix from India?
Contact Cordium Pharmaceuticals with the required product strength, quantity and buyer details to request availability and a quotation.
Sep 10th, 2026 5:56 PM

Keywords